MedPath

Antibiotics for prevention of wound infection in cesarean sectio

Not Applicable
Conditions
Health Condition 1: O85- Puerperal sepsis
Registration Number
CTRI/2019/08/020854
Lead Sponsor
Dr Krishna Agarwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Women with term pregnancy (37 to 41 completed weeks) undergoing elective or

emergency cesarean section

Exclusion Criteria

1. Women with clinical evidence of infection- fever or leucocytosis

2. Women already receiving or scheduled to receive antibiotic therapy for some other

reason

3. Moderate anemia (hb at enrolment)

4. Known HIV positivity

5. Women with heart disease needing antibiotic prophylaxis from prevention of SABE

6. Second stage caesarean section

7. Rupture of membranes ( >24hours)

8. Women with penicillin allergy

9. BMI > 30 kg/m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surgical site infection (SSI) according to CDC criteriaâ?? <br/ ><br>a. Superficial surgical site infection <br/ ><br>b. Deep surgical site infection <br/ ><br>c. Endometritis <br/ ><br>Endometritis would be identified by uterine tenderness, foul smelling lochia and <br/ ><br>fever â?¥100.40CTimepoint: 30 days postoperatively
Secondary Outcome Measures
NameTimeMethod
1. Womanâ??s duration of hospital stay <br/ ><br>2. Babyâ??s NICU/nursery stay i/v/o infection <br/ ><br>3. Readmission for surgical wound infection <br/ ><br>4. Side-effects related to antibiotics- Diarrhoea/vomiting/metallic taste <br/ ><br>5. Extravasation and thrombophlebitisTimepoint: 30 days of cesarean
© Copyright 2025. All Rights Reserved by MedPath